News tagged with lymphoma
Complications of blood cancers make termination advisable at early stages of pregnancy
Lymphoma is the fourth most common cancer in pregnancy, affecting one in 6000 pregnancies. Non-Hodgkin lymphoma, acute leukaemia, and other blood cancers, while also rare, can also occur in pregnancy. The need for urgent ...
Feb 09, 2012 |
not rated yet |
0
New therapy combination prolongs survival in dogs with lymphoma
A new immunotherapy for companion dogs with advanced-stage non-Hodgkin lymphoma (NHL) has been shown to improve survival while maintaining quality of life, according to a study published in the journal Scientific Reports. The st ...
Feb 07, 2012 |
5 / 5 (2) |
0
Amgen buys Micromet for anti-leukemia drug
Biotech giant Amgen said Thursday it was buying the German-American cancer research firm Micromet, giving it access to Micromet's promising leukemia therapy.
Jan 26, 2012 |
5 / 5 (1) |
0
A leukemia drug kills cancerous T-cells while sparing normal immunity
Leukemic cutaneous T-cell lymphoma (L-CTCL) is a leukemia arising from T-cells, a type of white blood cell. This cancer can involve the skin and other organs, and patients often die within three years.
Jan 25, 2012 |
4.8 / 5 (4) |
0
|
Novel treatment for skin lymphoma
Promising findings on a novel combination treatment approach for a chronic type of skin lymphoma are being published today (embargoed for 4 pm) in JAMA's Archives of Dermatology by clinical researchers from Seidman Cancer ...
Jan 17, 2012 |
5 / 5 (1) |
0
Scientists find genetic key to why some cancer patients don't respond to treatment
(Medical Xpress) -- Researchers from Newcastle University have identified a gene variation carried by 20% of the population which can significantly affect how patients with a rare type of blood cancer will respond to treatment.
Jan 05, 2012 |
5 / 5 (1) |
0
20 cancer cases in French women with PIP implants: agency
French health authorities said Friday that 20 cases of cancer had been uncovered in women with allegedly faulty French-made breast implants but insisted there was still no proven link with the disease.
Dec 30, 2011 |
not rated yet |
0
Autologous stem cell transplantation does not improve os in patients with follicular lymphoma
High-dose chemotherapy and autologous stem cell transplantation (HDC-ASCT), for previously untreated patients with advanced follicular lymphoma (FL) does not improve overall survival compared with conventional-dose chemotherapy ...
Dec 21, 2011 |
not rated yet |
0
PET technique promises better detection and response assessment for Non-Hodgkin's lymphoma
Positron emission tomography (PET) and a molecular imaging agent that captures the proliferation of cancer cells could prove to be a valuable method for imaging a form of Non-Hodgkin's disease called mantle cell lymphoma, ...
Dec 21, 2011 |
not rated yet |
0
Researchers identify genetic mutation responsible for most cases of Waldenstrom's macroglobulinemia
Scientists at Dana-Farber Cancer Institute have identified a gene mutation that underlies the vast majority of cases of Waldenstrom's macroglobulinemia, a rare form of lymphoma that has eluded all previous ...
Dec 12, 2011 |
5 / 5 (2) |
0
Study of two sisters sheds light on lymphoma evolution
When a 41-year-old woman was diagnosed with chronic-phase chronic myeloid leukemia, she received a bone marrow transplant and subsequent leukocyte infusion from her sister. These treatments controlled her leukemia, but seven ...
Dec 12, 2011 |
not rated yet |
0
American Society of Clinical Oncology issues annual report on progress against cancer
The American Society of Clinical Oncology (ASCO) today released Clinical Cancer Advances 2011: ASCO's Annual Report on Progress Against Cancer, an independent review of the advances in cancer research that have had the greatest ...
Dec 05, 2011 |
not rated yet |
0
New potential therapeutic target identified for Diffuse Large B-Cell Lymphoma
Researchers from the NYU Cancer Institute, an NCI-designated cancer center at NYU Langone Medical Center, have discovered a new potential therapeutic target for Diffuse Large B-Cell Lymphoma (DLBCL), the most aggressive and ...
Nov 28, 2011 |
5 / 5 (2) |
0
|
More intensive chemotherapy dramatically improves recurrence, survival in younger patients with aggressive lymphoma
Younger patients with diffuse large B-cell lymphoma given a more intensive regimen of chemotherapy combined with rituximab survive significantly longer, and are approximately twice as likely to remain in remission 3 years ...
Nov 24, 2011 |
not rated yet |
0
'If Hamlet give the first or second hit': The development of Burkitt's lymphoma
The human c-myc gene encodes a transcription factor (MYC) involved in the regulation of a vast number of other genes it has been estimated that the transcription of about one in six genes is somehow under the control ...
Nov 08, 2011 |
not rated yet |
0
Lymphoma
Lymphoma is a type of cancer that originates in lymphocytes of the immune system. They often originate in lymph nodes, presenting as an enlargement of the node (a tumor). Lymphomas are closely related to lymphoid leukemias, which also originate in lymphocytes but typically involve only circulating blood and the bone marrow (where blood cells are generated in a process termed haematopoesis) and do not usually form static tumours. There are many types of lymphomas, and in turn, lymphomas are a part of the broad group of diseases called hematological neoplasms.
Thomas Hodgkin published in 1832 the first description of lymphoma, specifically of the form named after him, Hodgkin's lymphoma. Since then many other forms of lymphoma have been described, grouped under several proposed classifications. The 1982 Working formulation classification became very popular. It introduced the category non-Hodgkin lymphoma (NHL), itself divided into 16 different diseases. However, since these different lymphomas have little in common with each other, the NHL label is of limited usefulness for doctors or patients and is slowly being abandoned. The latest classification by the WHO (2001) lists 43 different forms of lymphoma divided in four broad groups.
Some forms of lymphoma are indolent (e.g. small lymphocytic lymphoma), compatible with a long life even without treatment, whereas other forms are aggressive (e.g. Burkitt's lymphoma), causing rapid deterioration and death. The prognosis therefore depends on the correct classification of the disease, established by a pathologist after examination of a biopsy.
Although older classifications referred to histiocytic lymphomas, these are recognized in newer classifications as of B, T or NK cell lineage. True histiocytic malignancies are rare and are classified as sarcomas.
For more information about Lymphoma, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.